Tower Research Capital (TRC)’s Climb Bio, Inc. Common Stock CLYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.5K | Buy |
14,102
+5,972
| +73% | +$7.41K | ﹤0.01% | 3751 |
|
|
2025
Q1 | $9.92K | Buy |
8,130
+2,536
| +45% | +$3.09K | ﹤0.01% | 3705 |
|
|
2024
Q4 | $10.1K | Buy |
5,594
+3,037
| +119% | +$5.47K | ﹤0.01% | 3848 |
|
|
2024
Q3 | $13K | Sell |
2,557
-463
| -15% | -$2.36K | ﹤0.01% | 3547 |
|
|
2024
Q2 | $21.5K | Sell |
3,020
-586
| -16% | -$4.17K | ﹤0.01% | 3718 |
|
|
2024
Q1 | $9.88K | Buy |
3,606
+151
| +4% | +$414 | ﹤0.01% | 3779 |
|
|
2023
Q4 | $9.33K | Sell |
3,455
-441
| -11% | -$1.19K | ﹤0.01% | 4407 |
|
|
2023
Q3 | $10.2K | Sell |
3,896
-858
| -18% | -$2.26K | ﹤0.01% | 4134 |
|
|
2023
Q2 | $13.3K | Buy |
4,754
+1,492
| +46% | +$4.18K | ﹤0.01% | 3755 |
|
|
2023
Q1 | $9K | Buy |
3,262
+2,620
| +408% | +$7.23K | ﹤0.01% | 4558 |
|
|
2022
Q4 | $2K | Sell |
642
-339
| -35% | -$1.06K | ﹤0.01% | 5444 |
|
|
2022
Q3 | $3K | Buy |
981
+541
| +123% | +$1.65K | ﹤0.01% | 5445 |
|
|
2022
Q2 | $1K | Sell |
440
-1,991
| -82% | -$4.53K | ﹤0.01% | 5880 |
|
|
2022
Q1 | $20K | Buy |
2,431
+1,430
| +143% | +$11.8K | ﹤0.01% | 3554 |
|
|
2021
Q4 | $10K | Buy |
1,001
+510
| +104% | +$5.1K | ﹤0.01% | 4625 |
|
|
2021
Q3 | $9K | Buy |
+491
| New | +$9K | ﹤0.01% | 4479 |
|